The Specificity of Cervical Facet Medial Branch Blocks
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Cervical facet arthropathy is a common cause of chronic neck pain. The "gold standard" for diagnosis is either blocking the facet joints, or more commonly blocking the medial branch nerves that innervate the joints. However, many studies have found a high false-positive rate when the nerves are blocked using 0.5 ml of local anesthetic. We will randomize patients to receive either cervical facet medial branch blocks with 0.25 ml of local anesthetic and contrast, or 0.5 ml. We will then do a CT scan to determine the accuracy and specificity of each block. Our hypothesis is that using the higher volume (0.5 ml) might be responsible for the high false-positive rate.
| Condition | Intervention |
|---|---|
|
Neck Pain Cervical Facet Arthropathy |
Procedure: Cervical medial branch blocks |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Randomized Study Comparing the Accuracy and Specificity of Cervical Facet Medial Branch Blocks With 0.25 ml and 0.5 ml of Local Anesthetic |
- Accuracy of injections [ Time Frame: Immediately after nerve blocks. ] [ Designated as safety issue: No ]
- Pain relief after nerve blocks [ Time Frame: 8 hours after blocks ] [ Designated as safety issue: No ]
| Enrollment: | 20 |
| Study Start Date: | January 2008 |
| Study Completion Date: | April 2009 |
| Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Cervical medial branch blocks with 0.25 ml of injectate
|
Procedure: Cervical medial branch blocks
Cervical medial branch blocks done with 0.25 ml of local anesthetic and contrast
|
|
Experimental: 2
Cervical medial branch blocks with 0.5 ml of local anesthetic and contrast
|
Procedure: Cervical medial branch blocks
Cervical medial branch blocks with 0.5 ml of local anesthetic and contrast
|
Detailed Description:
Inclusion criteria: Dept. of Defense beneficiaries > 18 years of age; neck pain > 3 months duration; cervical paraspinal tenderness Exclusion criteria: Radicular signs or symptoms; use of anticoagulants or bleeding disorder.
Outcome measures: The number of blocks whereby the contrast bathes the target nerve; the number of blocks whereby the contrast spreads to the medial branch nerve at the adjacent spinal level; the number of times the contrast diffuses into the intervertebral foramen or epidural space. We will also compare pain relief over 8 hours following the block between both volumes.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age > 18 years
- Chronic neck pain > 3 months
- Paraspinal tenderness
Exclusion Criteria:
- Absence of radicular symptoms
- No bleeding diathesis
- Contrast allergy
Contacts and Locations| United States, District of Columbia | |
| Walter Reed Army Medical Center | |
| Washington, District of Columbia, United States, 20307 | |
| Principal Investigator: | Steven P Cohen, MD | Walter Reed Army Medical Center |
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Walter Reed Dept. of Clinical Investigation, Marty Green |
| ClinicalTrials.gov Identifier: | NCT00613340 History of Changes |
| Other Study ID Numbers: | NA-20008-A |
| Study First Received: | January 31, 2008 |
| Last Updated: | August 5, 2009 |
| Health Authority: | United States: Federal Government |
Keywords provided by Johns Hopkins University:
|
Cervical pain Zygapophysial joint Specificity |
Additional relevant MeSH terms:
|
Neck Pain Joint Diseases Pain Neurologic Manifestations Nervous System Diseases Signs and Symptoms Musculoskeletal Diseases Anesthetics, Local |
Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Sensory System Agents Peripheral Nervous System Agents Central Nervous System Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on May 16, 2013